Unknown

Dataset Information

0

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.


ABSTRACT: Glioblastoma (GBM), the most common primary brain tumor, is a complex and extremely aggressive disease. Despite recent advances in molecular biology, there is a lack of biomarkers, which would improve GBM's diagnosis, prognosis, and therapy. Here, we analyzed by qPCR the expression levels of a set of miRNAs in GBM and lower-grade glioma human tissue samples and performed a survival analysis in silico. We then determined the expression of same miRNAs and their selected target mRNAs in small extracellular vesicles (sEVs) of GBM cell lines. We showed that the expression of miR-21-5p was significantly increased in GBM tissue compared to lower-grade glioma and reference brain tissue, while miR-124-3p and miR-138-5p were overexpressed in reference brain tissue compared to GBM. We also demonstrated that miR-9-5p and miR-124-3p were overexpressed in the sEVs of GBM stem cell lines (NCH421k or NCH644, respectively) compared to the sEVs of all other GBM cell lines and astrocytes. VIM mRNA, a target of miR-124-3p and miR-138-5p, was overexpressed in the sEVs of U251 and U87 GBM cell lines compared to the sEVs of GBM stem cell line and also astrocytes. Our results suggest VIM mRNA, miR-9-5p miRNA, and miR-124-3p miRNA could serve as biomarkers of the sEVs of GBM cells.

SUBMITTER: Zottel A 

PROVIDER: S-EPMC7698225 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.

Zottel Alja A   Šamec Neja N   Kump Ana A   Raspor Dall'Olio Lucija Raspor LR   Pužar Dominkuš Pia P   Romih Rok R   Hudoklin Samo S   Mlakar Jernej J   Nikitin Daniil D   Sorokin Maxim M   Buzdin Anton A   Jovčevska Ivana I   Komel Radovan R  

International journal of molecular sciences 20201111 22


Glioblastoma (GBM), the most common primary brain tumor, is a complex and extremely aggressive disease. Despite recent advances in molecular biology, there is a lack of biomarkers, which would improve GBM's diagnosis, prognosis, and therapy. Here, we analyzed by qPCR the expression levels of a set of miRNAs in GBM and lower-grade glioma human tissue samples and performed a survival analysis <i>in silico</i>. We then determined the expression of same miRNAs and their selected target mRNAs in smal  ...[more]

Similar Datasets

| S-EPMC7391066 | biostudies-literature
| S-EPMC5421878 | biostudies-literature
| 2260465 | ecrin-mdr-crc
| S-EPMC9309285 | biostudies-literature
| S-EPMC8485335 | biostudies-literature
| S-EPMC8244143 | biostudies-literature
| S-EPMC3804457 | biostudies-literature
| S-EPMC4847810 | biostudies-other
| S-EPMC7662780 | biostudies-literature
| S-EPMC8147194 | biostudies-literature